
Overview
Financials
Revenue history (in k)
From the notes
| Profit allocation | Loss to be covered | |
| Related parties | 1 items | |
| Parent company | Tarczyński S.A. | |
| Shares in other companies |
Filing timeliness
Financial statements were filed on time, on average 1 day early.
- 202514/07/2026
- 202414/07/2025
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.
Results vs industry
Industry
Offer
- Food proteins
- Food ingredients
- Fermentation technologies
- Research and development
- Clean-label solutions
Website technology
- Website
- WordPress
- D Divi
Authorized Representatives
Manner of representation
In the case of a one-person management board, the member of the management board makes declarations on behalf of the company. In the case of a management board consisting of two or more persons, joint action by two members of the management board or by one member of the management board jointly with a commercial proxy is required to make declarations on behalf of the company.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
| 100,000 | $2,701,242.57 | 100% |
The articles of association require company consent for share transfers.
Beneficial owners
| Person | Rights |
|---|---|
Subsidiaries
| Name | Share value | Stake | ||
|---|---|---|---|---|
Tarczyński Agro 1 sp. z o.o. | 1,376,134.52 USD | 100% |
Bank accounts
Registered as a VAT taxpayer on 2024-06-04.
78 1020 1026 0000 1902 0656 7053
10 1020 1026 0000 1802 0742 2605
65 1020 1026 0000 1002 0742 2589
Debt
No entries in the National Debtors Register (KRZ).
Public aid
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Dec 17, 2025 | Aid for research and development projects: industrial research | –– | Dyrektor Narodowego Centrum Badań i Rozwoju | |
| Dec 17, 2025 | Aid for research and development projects: experimental development | –– | Dyrektor Narodowego Centrum Badań i Rozwoju |
European Funds
| Start | Project | EU co-financing | Programme | |
|---|---|---|---|---|
| 2026-03-01 | Development of a multifunctional protein preparation of microbial origin with catalytic properties for the production of meat substitutes | $1.1M$1,108,895 | European Funds for a Modern Economy |
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
| BDO register entry | Active |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Camino Science sp. z o.o. | $557,065.18 | camino.science | ||
| Pharmena S.A. | $541,436.46 | pharmena.eu | ||
| Result sp. z o.o. | $505,976.77 | result.biz.pl | ||
| Forvite P.S.A. | $468,502.70 | forvite.com | ||
| Medicofarma Biotech S.A. | $314,882.33 | medicofarmabiotech.pl | ||
| Bioactive-Tech sp. z o.o. | $228,068.15 | bioactivetech.pl | ||
| Fidelio Biogas sp. z o.o. | $197,684.83 | fideliobiogas.pl | ||
| Phage Consultants sp. z o.o. | $193,130.82 | phageconsultants.com | ||
| Food Sector P.S.A. | $180,336.24 | foodsector.pl | ||
| Fly-Gen sp. z o.o. | $45,325.87 | fly-gen.pl |
Change history
| Date | Event | |
|---|---|---|
| 2025-04-24 | Share capital increase (5,000,000.00 PLN → 10,000,000.00 PLN) | |
| 2024-05-24 | Entered in the register |
FAQ
Last updated: 2026-10-03